Aidoc: Building a Hospital-Centric AI Platform

In 2023, Israel-based AI health care company Aidoc evaluated its future. The company, founded in 2016, had grown from commercializing a single AI product for radiologists to a software platform that could detect 20 conditions and immediately notify care teams of critical results for priority patients. Aidoc's products detected over 75% of common acute pathologies visible on CT scans. The company had 20 algorithms used by over 900 global hospitals and had 17 FDA clearances-the highest number of any clinical AI company at the time. The company, which had initially produced point solutions, had evolved to manage a multisided network platform that hosted its own as well as its partners' algorithms. Aidoc had a rich history of producing highly accurate AI products, but partnership allowed it to bring more innovative products to market. The company needed to determine how to continue to grow. Should it focus more on developing highly technical AI health care solutions or on developing and managing a platform to bring other company's products to its growing customer base?